Researchers Linked Gut Microbiome to Heart Failure

New study finds specific gut bacteria can predict cardiac remodeling in patients with early-stage heart failure.

Updated on Oct. 14, 2026 in Heart Disease

Close-up of laboratory vials and delicate crystalline bacterial models on a clean white clinical surface.
Researchers have identified specific gut microbiome signatures that can predict cardiac remodeling in patients with early-stage heart failure. AI Illustration. Upload story photo >

Live Poll

Do you trust that gut health research will lead to better heart health outcomes?

Scientists have identified specific gut microbiome signatures that can predict whether patients with stage A or B heart failure will experience cardiac remodeling. The study used machine learning to achieve high accuracy in forecasting adverse or positive heart changes.

Why it matters

The findings suggest that the gut microbiome could become a critical tool for doctors to stratify patient risk and develop personalized management plans for heart disease. This approach potentially opens new avenues for therapeutic interventions targeting gut health.

Researchers achieved 0.76 accuracy for predicting adverse remodeling and 0.85 for reverse remodeling. These figures are supported by area under the curve metrics of 0.86 and 0.95 respectively.

The details

Researchers utilized full-length 16S rRNA sequencing of stool DNA to identify four key bacterial genera, including Romboutsia and Klebsiella, and five specific species such as K. pneumoniae. These findings allow for the classification of heart failure patients based on expected one-year cardiac outcomes.

Timeline

  1. Subjects were classified for remodeling status following a one-year follow-up period.

The Big Picture

This study advances the human gut microbiome research field by linking microbial composition to cardiovascular health. It provides a new paradigm for how non-invasive diagnostics could be integrated into routine cardiac patient management.

These findings suggest that future cardiac treatment plans may eventually include microbiome analysis to help predict long-term heart health. Patients may benefit from more personalized management strategies as these predictive models are refined and validated for clinical use.

The takeaway

The gut-heart axis continues to emerge as a vital area of study for understanding chronic conditions. Future personalized medicine may focus on modulating gut bacteria to improve patient outcomes in heart failure.

Further reading

For more on cardiovascular research, visit our Heart Disease section.

More information

Read the full results in the peer-reviewed research article published in the relevant scientific journal.

Source note: This article includes information reported by Nature.

Live Poll

Do you trust that gut health research will lead to better heart health outcomes?